{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T01:54:11Z","timestamp":1781920451654,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.ahj.2011.04.009","type":"journal-article","created":{"date-parts":[[2011,7,10]],"date-time":"2011-07-10T12:02:47Z","timestamp":1310299367000},"page":"89-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Cardiogenic shock and heart failure post\u2013percutaneous coronary intervention in ST-elevation myocardial infarction: Observations from \u201cAssessment of Pexelizumab in Acute Myocardial Infarction\u201d"],"prefix":"10.1016","volume":"162","author":[{"given":"John K.","family":"French","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal S.","family":"Kleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S.","family":"Hellkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Stebbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith S.","family":"Hochman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Mahaffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2011.04.009_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1067\/mhj.2003.53","article-title":"Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials","volume":"145","author":"Hasdai","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2011.04.009_bb0010","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1056\/NEJM199904153401504","article-title":"Temporal trends in cardiogenic shock complicating acute myocardial infarction","volume":"340","author":"Goldberg","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2011.04.009_bb0015","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1136\/bmj.312.7047.1637","article-title":"Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction","volume":"312","author":"French","year":"1996","journal-title":"Br Med J"},{"key":"10.1016\/j.ahj.2011.04.009_bb0020","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/jama.297.17.1892","article-title":"Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006","volume":"297","author":"Fox","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2011.04.009_bb0025","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ahj.2006.07.013","article-title":"Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States","volume":"152","author":"Fang","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2011.04.009_bb0030","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/CIRCULATIONAHA.108.814947","article-title":"Thirty-year trends (1975-2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction. A population-based perspective","volume":"119","author":"Goldberg","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2011.04.009_bb0035","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jama.285.2.190","article-title":"One-year survival following early revascularization for cardiogenic shock","volume":"285","author":"Hochman","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2011.04.009_bb0040","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/jama.294.4.448","article-title":"Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock","volume":"294","author":"Babaev","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2011.04.009_bb0045","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0735-1097(02)02173-3","article-title":"Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction. A report from the Second National Registry of Myocardial Infarction (NRMI-2)","volume":"40","author":"Audrey","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2011.04.009_bb0050","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.CIR.0000109691.16944.DA","article-title":"Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE)","volume":"109","author":"Steg","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2011.04.009_bb0055","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.ehj.2004.05.009","article-title":"Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarction","volume":"25","author":"Kashani","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2011.04.009_bb0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.297.1.43","article-title":"Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial","volume":"297","author":"The APEX AMI Investigators","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2011.04.009_bb0065","first-page":"II_317","article-title":"Efficient adjudication of endpoints in an international trial: strategic lessons from the Clinical Events Committee of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI)","volume":"116","author":"Mahaffey","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2011.04.009_bb0070","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/CIRCINTERVENTIONS.109.925180","article-title":"A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"3","author":"Stebbins","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2011.04.009_bb0075","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1161\/01.CIR.0000103122.10021.F2","article-title":"Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty data from the CAPTIM randomized clinical trial","volume":"108","author":"Steg","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2011.04.009_bb0080","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehm306","article-title":"Field triage to prima angioplasty combined with emergency department bypass reduces treatment delays and is associated with improved outcome","volume":"28","author":"Carstensen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2011.04.009_bb0085","doi-asserted-by":"crossref","first-page":"618","DOI":"10.7326\/0003-4819-149-9-200811040-00005","article-title":"Ten-tear trends in the incidence and treatment of cardiogenic shock","volume":"149","author":"Jeger","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2011.04.009_bb0090","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/01.CIR.0000087447.12918.85","article-title":"Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial","volume":"108","author":"Granger","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2011.04.009_bb0095","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.297.15.joc70035","article-title":"Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock the TRIUMPH randomized controlled trial","volume":"297","author":"The TRIUMPH Investigators","year":"2007","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ahj.2011.04.009_bb0100","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1161\/CIRCULATIONAHA.107.693986","article-title":"Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction","volume":"116","author":"Nicholls","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2011.04.009_bb0105","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/S0735-1097(02)02567-6","article-title":"Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction","volume":"40","author":"Dixon","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2011.04.009_bb0110","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.amjcard.2007.06.027","article-title":"Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials","volume":"100","author":"Stone","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2011.04.009_bb0115","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJMoa0706416","article-title":"Thrombus aspiration during primary percutaneous coronary intervention","volume":"358","author":"Svilaas","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2011.04.009_bb0120","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0002-9149(01)01802-1","article-title":"Effect on survival of acute myocardial infarction in Killip class II or III patients undergoing invasive coronary procedures","volume":"88","author":"Rott","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2011.04.009_bb0125","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/eurheartj\/ehq220","article-title":"Shock in acute myocardial infarction: the Cape Horn for trials?","volume":"31","author":"Thiele","year":"2010","journal-title":"Eur heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870311002754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870311002754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:45:26Z","timestamp":1757569526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870311002754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0002870311002754"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2011.04.009","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiogenic shock and heart failure post\u2013percutaneous coronary intervention in ST-elevation myocardial infarction: Observations from \u201cAssessment of Pexelizumab in Acute Myocardial Infarction\u201d","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2011.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}